Channel Therapeutics Corpora
13F holders, Q4 2024 (December 31)4holders −1
0new positions
1sold out
$0.64avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Channel Therapeutics Corpora in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Two Sigma Securities, LLC ($9K), Wealth Enhancement Advisory Services, LLC ($7K) and Tower Research Capital LLC (TRC) ($162).
- Company
- Channel Therapeutics Corpora
- CUSIP
- 171126105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 1 shares bought and 58,925 shares sold, net −58,924 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Two Sigma Securities, LLC | 0.00% | Reduce -45.0% | 14,347 | $9K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 10,400 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -2.3% | 253 | $162 |
| Bank of America Corp. | 0.00% | Add +9.1% | 12 | $8 |
"% of holder's portfolio" is CHANNEL THERAPEUTICS CORPORA's weight in each manager's 13F, not the share of Channel Therapeutics Corpora the manager owns.